The American College of Obstetricians and Gynecologists supports vaginal hysterectomy as the safest and most costeffective route. While the cost-benefit ratio is favorable, there are still opportunities to optimize efficiency and contain cost. Several studies have highlighted the low instrument utilization within surgical trays, which leading to increased processing costs and surgical case setup time. Other risks related to excess surgical instruments include a reduction in instrument longevity from preventable wear-and-tear, increased risk for tray assembly errors, and strain placed on operating suite staff from tray weight. A previous study in gynecologic surgery reported as few as 13% of surgical instruments on a vaginal surgery tray were used. We aimed to evaluate the instrument usage within our vaginal hysterectomy trays to reduce unnecessary instruments without compromising high quality, safe patient care. Further, we estimated cost savings from the development of a "minor gynecology" tray that could replace the vaginal hysterectomy tray previously used for benign outpatient vaginal cases.
OBJECTIVES:
The American College of Obstetricians and Gynecologists supports vaginal hysterectomy as the safest and most costeffective route. While the cost-benefit ratio is favorable, there are still opportunities to optimize efficiency and contain cost. Several studies have highlighted the low instrument utilization within surgical trays, which leading to increased processing costs and surgical case setup time. Other risks related to excess surgical instruments include a reduction in instrument longevity from preventable wear-and-tear, increased risk for tray assembly errors, and strain placed on operating suite staff from tray weight. A previous study in gynecologic surgery reported as few as 13% of surgical instruments on a vaginal surgery tray were used. We aimed to evaluate the instrument usage within our vaginal hysterectomy trays to reduce unnecessary instruments without compromising high quality, safe patient care. Further, we estimated cost savings from the development of a "minor gynecology" tray that could replace the vaginal hysterectomy tray previously used for benign outpatient vaginal cases.
MATERIALS AND METHODS:
The Female Pelvic Medicine and Reconstructive Surgeons (FPRMS) and operating suite staff first eliminated extraneous instruments based on clinical experience. Following that initial reduction, the Surgical Quality Committee initiated a formal audit of surgical instrument usage. The vaginal hysterectomy tray was used for major benign gynecology cases, including vaginal hysterectomy with and without pelvic reconstruction, urogenital and rectovaginal fistulas approached vaginally, and vaginal mesh removal. Minor gynecology cases included isolated anterior or posterior repairs, Bartholin cyst/labial lesions, urethral diverticulum, and midurethral sling placement or revision. Cost of sterile processing and packaging was estimated to be $0.51/instrument based on published data. RESULTS: The standard vaginal hysterectomy tray contains 67 instruments. This was reduced to 48 instruments in the minor gynecology tray. Processing costs were estimated to be $34.17/vaginal hysterectomy tray and $24.48/minor gynecology tray. Instrument usage for the vaginal hysterectomy tray averaged 66%, which is higher than what has been reported by other studies in gynecology. In 2015, four FPRMS specialists at our institution performed 844 cases. The cost to process the instruments for those cases would have been $28,839.48 prior to the development of the minor gynecology tray. Estimating that the minor gynecology tray could be used for 20% of those cases, we achieved a cost savings of 5.7% ($1637.61) . CONCLUSION: Healthcare costs related to set-up, processing and packaging of unused surgical instruments can be reduced when surgeons and operating suite staff work together to identify opportunities to reduce inefficiencies. Cost savings are likely underestimated due to the surgeon-and operating suite staffdriven initiative to reduce the number of instruments in each tray prior to the formal audit. The development of a minor gynecology tray resulted in a modest cost savings within this department, but advantages regarding time to set-up and process instruments as well as instrument longevity cannot be understated.
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73 Clinical characteristics and outcomes of patients undergoing contained extracorporeal manual tissue extraction OBJECTIVES: The objective of this study was to describe the clinical characteristics and perioperative outcomes of patients undergoing contained extracorporeal manual tissue extraction after laparoscopic hysterectomy or laparoscopic myomectomy. MATERIALS AND METHODS: This is a multicenter retrospective study of 169 consecutive women who underwent a minimally invasive hysterectomy or myomectomy with subsequent specimen retrieval using contained extracorporeal manual tissue extraction through an extended umbilical incision from April 18, 2014 to June 1, 2016. Demographic variables and perioperative variables were collected. Upon completion of the surgical procedure, the umbilical incision was extended vertically through the base of the umbilicus to approximately 3 cm. The containment bag was introduced and the specimen(s) were placed into the containment bag. The containment bag was then exteriorized through the umbilical incision onto the abdomen. A self-retaining wound retractor was then placed within the containment bag at the umbilicus. The specimen(s) were then elevated through the self-retaining retractor, and excised extracorporeally with a scalpel manually. The containment bag and selfretaining retractor were then exteriorized from the abdomen, and the integrity of the containment system was examined visually by the surgeon. The 3 cm umbilical fascia incision was closed with PDS suture in a running fashion. Skin incisions were reapproximated in standard fashion (Figure 1 ). Patients were evaluated at 2 weeks and then at 6 weeks post-operatively. Mean and SD are presented for continuous variables; categorical variables are presented using frequency. RESULTS: The mean age was 41.9 years (+/-8.5) (TLH: 48.1 +/-7.1; LM: 36.2 +/-5.0). The majority of patients undergoing surgery were of white race with an average BMI of 28.4 m/kg 2 (+/-7.6) (TLH: 30.8 m/kg 2 (+/-8.4); LM: 25.8 m/kg 2 (+/-5.1). Approximately 49% of patients had undergone prior surgery (TLH: 28.9%; LM: 62.0%). The predominant indication for surgery was symptomatic uterine fibroids (TLH: 90.0%; LM: 100%;), followed by pelvic pain (TLH: 57.8%; LM: 49.4%), dysmenorrhea (TLH: 55.6%; LM: 45.6%), and menorrhagia (TLH: 52.2%, LM: 39.2%). The mean operative time was 230.6 minutes (+/-85.9) (TLH: 229 minutes (+/-64.7); LM: 232.4 minutes (+/-103.6). The mean estimated blood loss was 260.0 mL (+/-521.0) (TLH: 105.6 mL (+/-101.3); LM: 311.7 mL (+/-411.6). The mean specimen weight was 579.9 g (+/-384.6) (TLH: 736.2 g (+/-406.7); LM: 401.8 g (+/-346.8). One hundred sixty-two patients (95.8%) were discharged to home within one day or less. Final pathological diagnosis was benign in 99.4% of the cases. Uterine leiomyoma was the most common final pathology diagnosis. Occult malignancy was identified in one patient. There were no conversions to an open approach, no instances of containment bag tear or gross spillage during the manual tissue extraction process, and no complications related to the tissue extraction technique. CONCLUSION: Contained extracorporeal manual tissue extraction through an extended umbilical incision is a safe and feasible technique in women undergoing laparoscopic hysterectomy and laparoscopic myomectomy.
Post-op skin closure DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS: Douglas N. Brown: Nothing to disclose; Deirdre Lum: Nothing to disclose. -8) , and the Urinary Distress Inventory (UDI-6). Scores on both the Symptom Severity subscale of the UFS-QOL and the PFDI-20 range from 0 to 100, with higher scores indicating greater symptom severity or bother. RESULTS: One hundred ninety-five women with mean age of 41 AE 6 years and BMI of 29 AE 7 kg/m 2 were included in this analysis. Fiftyeight percent identified as black, 32% as white, and 6% as Asian. Median parity was 0 (0-4) with 38% of women having had at least one vaginal delivery. Mean age at fibroid diagnosis was 34 AE 7 years. Women commonly attributed heavy vaginal bleeding (81%), pelvic pain (68%), increased abdominal size (66%), length of menses (56%), dyspareunia (37%), and urinary incontinence (31%) to their fibroids. The mean UFS-QOL Symptom Severity subscale score was 48.7 AE 25.4 for the cohort, with 81% of participants reporting being at least "somewhat bothered" by heavy bleeding during menses, 79% by passing clots, 66% by feeling fatigued, 63% by tightness or pressure in pelvic area, 60% by frequent daytime urination, and 47% by frequent night time urination. Mean PFDI-20 score was 45.5 AE 31.9 for the cohort with mean subscale scores of 17.2 AE 12.2, 9.3 AE 10.7, and 19.0 AE 15.8 for the POPDI-6, CRADI-8, and UDI-6, respectively. Women most commonly reported being at least "somewhat bothered" by pressure in the abdomen (71%), heaviness or dullness in the pelvis (60%), frequent urination (56%), pelvic pain or discomfort (48%), sensation of incomplete bladder emptying (43%), and incomplete emptying at the end of a bowel movement (42%). Fewer women reported bother from stress urinary incontinence (36%), urgency urinary incontinence (35%), and difficulty with bladder emptying (21%). Other pelvic floor symptoms such as vaginal bulge (15%), needing to push on the vagina or around the rectum to complete a bowel movement (12%), and needing to push in the vagina to initiate or complete urination (7%) were uncommon. CONCLUSION: Women presenting for evaluation and treatment of fibroids report high rates of pelvic floor symptom bother, particularly related to urinary frequency and pelvic pressure. Given the observed frequency of pelvic floor symptoms, future studies should assess interventions for pelvic floor dysfunction in this patient population.
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